UNSPSC 51422365: Prednisolone sodium succinate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H31O8.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8223RR9DWF, chemically known as 11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(hydrogen succinate) but more generally known as prednisolone sodium succinate, which bears US NIH Compound Identifier 4897. European Medicines Agency schedules Prednisolone sodium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04019MIG.

UNSPSC 51422365 Prednisolone sodium succinate is a Commodity code that nominally describes a specific pharmaceutical product, but the recent state and local procurement activity posted under it does not reflect that scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—products unrelated to prednisolone sodium succinate. The code shows little relevant recent activity aligned with its abstract name.

The single recent opportunity supporting this code is Seminole County's competitive bid for Naloxone and drug deactivation systems, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, potential FEMA funding, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, workers' compensation, and commercial general liability insurance. No set-aside designations are specified. Absent further opportunities in the recent block, this code warrants close verification before pursuit—the posted opportunity does not align with the commodity's stated pharmaceutical scope, suggesting either a tagging error or a code used outside its intended taxonomy.